Notes / Company

Kimia Biosciences Ltd.

KIMIABL BSE 530313 ISIN INE285U01025 Pharmaceuticals

Fundamentals

Market cap: ₹173 cr
P/E: 17.97×
ROE: 96.45%
Debt / equity: 3.27
52-week range: 23.20 — 86.85

The timeline — 1 note on Kimia Biosciences Ltd.

May 2026

29 May 26 · 7:05 PM IST Brief

Brief · Earnings · Micro cap

Kimia Biosciences posts FY26 results, nothing new under the sun

Audited standalone results for the quarter and year ended March 31, 2026, are in. The filing adds nothing to the existing view.

Verify on exchange BSE filings for KIMIABL NSE filings for KIMIABL